Syncona Partners Visit | Independent investment subsidiary of Wellcome Trust
| Dates: | 2 April 2015 |
|---|
| Times: | 10:30 - 12:45 |
|---|
| What is it: | Talk |
|---|
| Organiser: | Faculty of Medical and Human Sciences |
|---|
| Who is it for: | University staff |
|---|
|
Host:
About the event:
UMIP are hosting an event with Syncona Partners and we would like to invite you to attend.
Iraj Ali, partner of Syncona Partners, is joining us to give a talk to an invited audience of academics, University business managers and UMIP about Syncona’s investment strategy and interests. This will then be followed by a number of pre-booked 30 minute 121 sessions with individuals who might have ideas to discuss.
Areas of Interest:
Syncona Partners are interested in Gene and Cell Therapy, including:
- Engineered Cell Therapy
- T-cell focus
- Chimeric antigen receptor approaches
- Extreme efficacy in end-stage cancer patients
- Autologous product delivery infrastructure)
- Patient Stratification
- Patient selection to deliver extreme efficacy
- Clinical genomics
- Molecular Imaging
- Gene Therapy
- Lentiviral and AAV vector delivery
- Severe monogenic disorders
- Eye, liver, CNS opportunities
- Pediatricinherited diseases
- Targeted Medicine is a theme common to all Target Areas
- Extreme efficacy in targeted patient groups
- Health-economic outcomes and reimbursement driven by patient targeting
They are actively exploring new Health Care Investment Themes (“HIT”)
Registration:
Please register for this event, using Eventbrite
Travel and Contact Information
Find event
Core Technology Facility
Manchester
